octobre 26, 2023
Navigating the Foreign Agents Registration Act (FARA): Where is DOJ Headed?
octobre 26, 2023
An Update on No Surprises Act Implementation and Developments on the Hospital Price Transparency Rule
octobre 10, 2023
Key Food and Beverage Issues: Recent Developments in False Advertising Litigation in the U.S and the European Union
septembre 27, 2023
At Last! FDA Issues Final Guidance on Use of Real-World Evidence for Regulatory Decision-Making for Drug and Biological Products
septembre 19, 2023
2023 IPPS Final Rule: Analysis and Opportunity
août 29, 2023
Investigations & Enforcement Developments for Life Sciences and Healthcare Companies
juillet 25, 2023
Insider Trading and the Life Sciences – Recent Developments and Potential Pitfalls for Pharmaceutical, Medical Device, and Life Sciences Companies
juillet 11, 2023
Virtual Talk im Turm – Update MiFID III: Retail Investment Package
juin 20, 2023
New Developments in Regulatory Review Requirements for Healthcare M&A Transactions
juin 8, 2023
Are You Ready? The New FDA Requirement for Diversity Action Plans in Drug and Device Clinical Investigations
mai 10, 2023
Talk im Turm – Parallel Import: ECJ Reboxing vs. Relabeling Decision
avril 20, 2023
Revision of the EU Pharmaceutical Legislation - What To Expect